These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9785591)

  • 41. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
    Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
    Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of cyclosporine on the development of cerebral vasospasm in a primate model.
    Handa Y; Hayashi M; Takeuchi H; Kobayashi H; Kawano H; Kabuto M
    Neurosurgery; 1991 Mar; 28(3):380-5; discussion 385-6. PubMed ID: 2011219
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke.
    Li M; Chen S; Shi X; Lyu C; Zhang Y; Tan M; Wang C; Zang N; Liu X; Hu Y; Shen J; Zhou L; Gu Y
    J Neuroinflammation; 2018 Aug; 15(1):237. PubMed ID: 30139371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intraventricular tissue plasminogen activator in subarachnoid hemorrhage patients: a prospective, randomized, placebo-controlled pilot trial.
    Kramer AH; Roberts DJ; Holodinsky J; Todd S; Hill MD; Zygun DA; Faris P; Wong JH
    Neurocrit Care; 2014 Oct; 21(2):275-84. PubMed ID: 24627207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthetic, organic compound vepoloxamer (P-188) potentiates tissue plasminogen activator.
    Dansdill D; Halandras PM; Beverly J; Jeske W; Hoppensteadt D; Emanuele M; Fareed J; Cho JS
    J Vasc Surg; 2018 Jan; 67(1):294-299. PubMed ID: 27939143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Failure of intracisternal tissue plasminogen activator to prevent vasospasm in certain patients with aneurysmal subarachnoid hemorrhage.
    Steinberg GK; Vanefsky MA; Marks MP; Adler JR; Koenig GH
    Neurosurgery; 1994 May; 34(5):809-13; discussion 813-4. PubMed ID: 8052377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage.
    Pluta RM; Oldfield EH; Boock RJ
    J Neurosurg; 1997 Nov; 87(5):746-51. PubMed ID: 9347984
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Erythrocyte-Inspired Discoidal Polymeric Nanoconstructs Carrying Tissue Plasminogen Activator for the Enhanced Lysis of Blood Clots.
    Colasuonno M; Palange AL; Aid R; Ferreira M; Mollica H; Palomba R; Emdin M; Del Sette M; Chauvierre C; Letourneur D; Decuzzi P
    ACS Nano; 2018 Dec; 12(12):12224-12237. PubMed ID: 30427660
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Zabramski JM; Spetzler RF; Lee KS; Papadopoulos SM; Bovill E; Zimmerman RS; Bederson JB
    J Neurosurg; 1991 Aug; 75(2):189-96. PubMed ID: 1906534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intraventricular tissue plasminogen activator for the prevention of vasospasm and hydrocephalus after aneurysmal subarachnoid hemorrhage.
    Ramakrishna R; Sekhar LN; Ramanathan D; Temkin N; Hallam D; Ghodke BV; Kim LJ
    Neurosurgery; 2010 Jul; 67(1):110-7; discussion 117. PubMed ID: 20559098
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of tissue plasminogen activator on intimal platelet accumulation in cerebral arteries after subarachnoid hemorrhage in cats.
    Yamamoto Y; Clower BR; Haining JL; Smith RR
    Stroke; 1991 Jun; 22(6):780-4. PubMed ID: 1905429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early treatment of subarachnoid hemorrhage after preventing rerupture of an aneurysm.
    Kinugasa K; Kamata I; Hirotsune N; Tokunaga K; Sugiu K; Handa A; Nakashima H; Ohmoto T; Mandai S; Matsumoto Y
    J Neurosurg; 1995 Jul; 83(1):34-41. PubMed ID: 7782847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.
    Jin R; Xiao AY; Liu S; Wang M; Li G
    Stroke; 2018 Jul; 49(7):1708-1718. PubMed ID: 29844028
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Computer simulation of systemic circulation and clot lysis dynamics during thrombolytic therapy that accounts for inner clot transport and reaction.
    Anand S; Diamond SL
    Circulation; 1996 Aug; 94(4):763-74. PubMed ID: 8772700
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility.
    Barber PA; Zhang J; Demchuk AM; Hill MD; Buchan AM
    Neurology; 2001 Apr; 56(8):1015-20. PubMed ID: 11320171
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
    J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain.
    Zhang W; Sato K; Hayashi T; Omori N; Nagano I; Kato S; Horiuchi S; Abe K
    Neurol Res; 2004 Apr; 26(3):342-8. PubMed ID: 15142331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Direct tissue plasminogen activator administration through a microinjection device in a pig model of retinal vein thrombosis.
    Zhang X; Ma Z; Hu Y; Fan J
    Curr Eye Res; 2002 Apr; 24(4):263-7. PubMed ID: 12324864
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 1: Clinical and radiological findings.
    Espinosa F; Weir B; Overton T; Castor W; Grace M; Boisvert D
    J Neurosurg; 1984 Jun; 60(6):1167-75. PubMed ID: 6726360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.